These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14671871)

  • 1. NICE appraisals and cardiology: glycoprotein IIb/IIIa inhibitors and acute coronary syndromes.
    Hyde T; Knight C
    Hosp Med; 2003 Nov; 64(11):638-9. PubMed ID: 14671871
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
    Silva MA; Donovan JL; Gandhi PJ; Volturo GA
    Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa inhibitors and acute coronary syndromes: summary report of the full submission to NICE, and beyond.
    Manoharan G; Adgey AA
    Heart; 2001 Sep; 86(3):259-61. PubMed ID: 11514474
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of platelet glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndrome and coronary intervention].
    Kakuta T; Kishi Y; Numano F
    Nihon Rinsho; 1998 Oct; 56(10):2630-4. PubMed ID: 9796330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes.
    Koller CF
    Heart Lung; 2001; 30(5):321-9; quiz 330-1. PubMed ID: 11604974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Harding SA; Boon NA; Flapan AD
    Lancet; 2002 Jul; 360(9328):256-7. PubMed ID: 12133681
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes.
    Elmouchi DA; Bates ER
    Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glycoprotein IIB/IIIA receptor blockers as treatment of acute coronary syndromes and interventional cardiology].
    Abramovitch N; Halon DA; Flugelman Y; Lewis BS
    Harefuah; 1998 Jul; 135(1-2):41-7. PubMed ID: 10909532
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Maree A; Fitzgerald D
    Haematologica; 2001 Nov; 86(11 Suppl 2):45-8. PubMed ID: 11926777
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.
    Alexander JH; Harrington RA
    Drugs; 1998 Dec; 56(6):965-76. PubMed ID: 9878986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPIIb-IIIa receptor inhibitors: what the interventional radiologist needs to know.
    Hofmann LV; Razavi M; Arepally A; Reginelli JP; Resar J; Geschwind JF; Corl F
    Cardiovasc Intervent Radiol; 2001; 24(6):361-7. PubMed ID: 11907740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
    Van de Werf F
    Thromb Haemost; 1997 Jul; 78(1):210-3. PubMed ID: 9198155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
    Pieper KS; Tsiatis AA; Davidian M; Hasselblad V; Kleiman NS; Boersma E; Chang WC; Griffin J; Armstrong PW; Califf RM; Harrington RA
    Circulation; 2004 Feb; 109(5):641-6. PubMed ID: 14769687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Which, when, how?].
    Juárez Herrera U
    Arch Cardiol Mex; 2001; 71 Suppl 1():S85-90. PubMed ID: 11565353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
    Tricoci P; Peterson ED
    J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes.
    Stringer KA
    Ann Pharmacother; 1999 Jun; 33(6):712-22. PubMed ID: 10410186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?
    Maree A; Fitzgerald DJ
    Semin Vasc Med; 2003 Nov; 3(4):385-90. PubMed ID: 15199445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Landolfi R; De Cristofaro R
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133682
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133683
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Boersma E; Harrington RA; Moliterno DJ; White H; Simoons ML
    Lancet; 2002 Jul; 360(9329):342-3. PubMed ID: 12147403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.